Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.

Salminen AP, Koskinen I, Perez IM, Hurme S, Murtola TJ, Vaarala MH, Nykopp TK, Seppänen M, Isotalo T, Marttila T, Levomäki L, Becker S, Anttinen M, Liukkonen T, Säily M, Pogodin-Hannolainen D, Viitanen J, Palmberg C, Ottelin J, Sairanen J, Ettala OO, Boström PJ.

Eur Urol Oncol. 2018 Dec;1(6):525-530. doi: 10.1016/j.euo.2018.06.014. Epub 2018 Jul 14.

PMID:
31158099
2.

AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging.

Salminen A, Kauppinen A, Kaarniranta K.

J Mol Med (Berl). 2019 May 25. doi: 10.1007/s00109-019-01795-9. [Epub ahead of print] Review.

PMID:
31129755
3.

Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency.

Salminen A, Kaarniranta K, Kauppinen A.

Cell Mol Life Sci. 2019 May;76(10):1901-1918. doi: 10.1007/s00018-019-03048-x. Epub 2019 Feb 20. Review.

4.

Reply to: A note on rotigotine for restless legs syndrome after renal transplantation.

Salminen AV, Allen RP, Högl B, Inoue Y, Oertel W, Winkelman JW, Trenkwalder C, Sampaio C, Winkelmann J.

Mov Disord. 2019 Jan;34(1):152-153. doi: 10.1002/mds.27570. No abstract available.

PMID:
30653726
5.

Reply to: Safety of dopamine agonists for treating restless legs syndrome.

Salminen AV, Allen RP, Högl B, Inoue Y, Oertel W, Winkelman JW, Trenkwalder C, Sampaio C, Winkelmann J.

Mov Disord. 2019 Jan;34(1):150-151. doi: 10.1002/mds.27571. No abstract available.

PMID:
30653723
6.

Ultrathin Dual-Scale Nano- and Microporous Membranes for Vascular Transmigration Models.

Salminen AT, Zhang J, Madejski GR, Khire TS, Waugh RE, McGrath JL, Gaborski TR.

Small. 2019 Feb;15(6):e1804111. doi: 10.1002/smll.201804111. Epub 2019 Jan 11.

PMID:
30632319
7.

Protein Separation and Hemocompatibility of Nitride Membranes in Microfluidic Filtration Systems.

Salminen A, Hill K, Henry Chung L, James McGrath L, Johnson DG.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:5814-5817. doi: 10.1109/EMBC.2018.8513538.

8.

Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update.

Salminen AV, Winkelmann J.

Curr Treat Options Neurol. 2018 Nov 9;20(12):55. doi: 10.1007/s11940-018-0540-3. Review.

PMID:
30411165
9.

Loss of NRF-2 and PGC-1α genes leads to retinal pigment epithelium damage resembling dry age-related macular degeneration.

Felszeghy S, Viiri J, Paterno JJ, Hyttinen JMT, Koskela A, Chen M, Leinonen H, Tanila H, Kivinen N, Koistinen A, Toropainen E, Amadio M, Smedowski A, Reinisalo M, Winiarczyk M, Mackiewicz J, Mutikainen M, Ruotsalainen AK, Kettunen M, Jokivarsi K, Sinha D, Kinnunen K, Petrovski G, Blasiak J, Bjørkøy G, Koskelainen A, Skottman H, Urtti A, Salminen A, Kannan R, Ferrington DA, Xu H, Levonen AL, Tavi P, Kauppinen A, Kaarniranta K.

Redox Biol. 2019 Jan;20:1-12. doi: 10.1016/j.redox.2018.09.011. Epub 2018 Sep 14.

10.

The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process.

Salminen A, Kaarniranta K, Kauppinen A.

Ageing Res Rev. 2018 Dec;48:1-10. doi: 10.1016/j.arr.2018.09.001. Epub 2018 Sep 21. Review.

PMID:
30248408
11.

Salivary biomarkers in association with periodontal parameters and the periodontitis risk haplotype.

Liukkonen J, Gürsoy UK, Könönen E, Gürsoy M, Metso J, Salminen A, Kopra E, Jauhiainen M, Mäntylä P, Buhlin K, Paju S, Sorsa T, Nieminen MS, Lokki ML, Sinisalo J, Pussinen PJ.

Innate Immun. 2018 Oct;24(7):439-447. doi: 10.1177/1753425918796207. Epub 2018 Sep 3.

PMID:
30176756
12.

11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial).

Salminen A, Jambor I, Merisaari H, Ettala O, Virtanen J, Koskinen I, Veskimae E, Sairanen J, Taimen P, Kemppainen J, Minn H, Boström PJ.

Cancer Imaging. 2018 Aug 2;18(1):25. doi: 10.1186/s40644-018-0158-4.

13.

Fatty acids and oxidized lipoproteins contribute to autophagy and innate immunity responses upon the degeneration of retinal pigment epithelium and development of age-related macular degeneration.

Kaarniranta K, Koskela A, Felszeghy S, Kivinen N, Salminen A, Kauppinen A.

Biochimie. 2019 Apr;159:49-54. doi: 10.1016/j.biochi.2018.07.010. Epub 2018 Jul 18. Review.

PMID:
30031036
14.

Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence.

Salminen A, Kauppinen A, Kaarniranta K.

Biogerontology. 2018 Oct;19(5):325-339. doi: 10.1007/s10522-018-9762-8. Epub 2018 Jun 29. Review.

PMID:
29959657
15.

Feasibility and psychometric properties of the Finnish version of the measure of processes of care for adults.

Jeglinsky I, Karhula M, Salminen AL, Törmäkangas T.

Clin Rehabil. 2018 Nov;32(11):1540-1550. doi: 10.1177/0269215518784334. Epub 2018 Jun 27.

PMID:
29945458
16.

Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.

Salminen A, Kaarniranta K, Kauppinen A.

Int Immunopharmacol. 2018 Aug;61:231-240. doi: 10.1016/j.intimp.2018.06.005. Epub 2018 Jun 9. Review.

PMID:
29894862
17.

Perceived burden among spouse, adult child, and parent caregivers.

Juntunen K, Salminen AL, Törmäkangas T, Tillman P, Leinonen K, Nikander R.

J Adv Nurs. 2018 Oct;74(10):2340-2350. doi: 10.1111/jan.13733. Epub 2018 Jul 8.

PMID:
29869807
18.

The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease.

Salminen A, Kaarniranta K, Kauppinen A.

Cell Mol Life Sci. 2018 Sep;75(17):3099-3120. doi: 10.1007/s00018-018-2844-6. Epub 2018 May 19. Review.

PMID:
29779041
19.

Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)§.

Winkelmann J, Allen RP, Högl B, Inoue Y, Oertel W, Salminen AV, Winkelman JW, Trenkwalder C, Sampaio C.

Mov Disord. 2018 Jul;33(7):1077-1091. doi: 10.1002/mds.27260. Epub 2018 May 14. Review.

PMID:
29756335
20.

NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease.

Uusimaa J, Kaarteenaho R, Paakkola T, Tuominen H, Karjalainen MK, Nadaf J, Varilo T, Uusi-Mäkelä M, Suo-Palosaari M, Pietilä I, Hiltunen AE, Ruddock L, Alanen H, Biterova E, Miinalainen I, Salminen A, Soininen R, Manninen A, Sormunen R, Kaakinen M, Vuolteenaho R, Herva R, Vieira P, Dunder T, Kokkonen H, Moilanen JS, Rantala H, Nogee LM, Majewski J, Rämet M, Hallman M, Hinttala R.

Acta Neuropathol. 2018 May;135(5):727-742. doi: 10.1007/s00401-018-1817-z. Epub 2018 Feb 8.

PMID:
29423877
21.

Aggregatibacter actinomycetemcomitans serotypes associate with periodontal and coronary artery disease status.

Pietiäinen M, Kopra KAE, Vuorenkoski J, Salminen A, Paju S, Mäntylä P, Buhlin K, Liljestrand JM, Nieminen MS, Sinisalo J, Hyvärinen K, Pussinen PJ.

J Clin Periodontol. 2018 Apr;45(4):413-421. doi: 10.1111/jcpe.12873. Epub 2018 Mar 15.

PMID:
29385645
22.

Mu transpososome activity-profiling yields hyperactive MuA variants for highly efficient genetic and genome engineering.

Rasila TS, Pulkkinen E, Kiljunen S, Haapa-Paananen S, Pajunen MI, Salminen A, Paulin L, Vihinen M, Rice PA, Savilahti H.

Nucleic Acids Res. 2018 May 18;46(9):4649-4661. doi: 10.1093/nar/gkx1281.

23.

MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.

Holli-Helenius K, Salminen A, Rinta-Kiikka I, Koskivuo I, Brück N, Boström P, Parkkola R.

BMC Med Imaging. 2017 Dec 29;17(1):69. doi: 10.1186/s12880-017-0239-z.

24.

Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis.

Salminen A, Vlachopoulou E, Havulinna AS, Tervahartiala T, Sattler W, Lokki ML, Nieminen MS, Perola M, Salomaa V, Sinisalo J, Meri S, Sorsa T, Pussinen PJ.

Circ Cardiovasc Genet. 2017 Dec;10(6). pii: e001731. doi: 10.1161/CIRCGENETICS.117.001731.

PMID:
29212897
25.

Expression of CPPED1 in human trophoblasts is associated with timing of term birth.

Haapalainen AM, Karjalainen MK, Daddali R, Ohlmeier S, Anttonen J, Määttä TA, Salminen A, Mahlman M, Bergmann U, Mäkikallio K, Ojaniemi M, Hallman M, Rämet M.

J Cell Mol Med. 2018 Feb;22(2):968-981. doi: 10.1111/jcmm.13402. Epub 2017 Nov 29.

26.

Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis.

Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, Dauvilliers Y, Stefani A, Högl B, Poewe W, Kemlink D, Sonka K, Bachmann CG, Paulus W, Trenkwalder C, Oertel WH, Hornyak M, Teder-Laving M, Metspalu A, Hadjigeorgiou GM, Polo O, Fietze I, Ross OA, Wszolek Z, Butterworth AS, Soranzo N, Ouwehand WH, Roberts DJ, Danesh J, Allen RP, Earley CJ, Ondo WG, Xiong L, Montplaisir J, Gan-Or Z, Perola M, Vodicka P, Dina C, Franke A, Tittmann L, Stewart AFR, Shah SH, Gieger C, Peters A, Rouleau GA, Berger K, Oexle K, Di Angelantonio E, Hinds DA, Müller-Myhsok B, Winkelmann J; 23andMe Research Team; DESIR study group.

Lancet Neurol. 2017 Nov;16(11):898-907. doi: 10.1016/S1474-4422(17)30327-7. Review.

27.

Inorganic pyrophosphatases of Family II-two decades after their discovery.

Baykov AA, Anashkin VA, Salminen A, Lahti R.

FEBS Lett. 2017 Oct;591(20):3225-3234. doi: 10.1002/1873-3468.12877. Epub 2017 Oct 17. Review.

28.

Integrated stress response stimulates FGF21 expression: Systemic enhancer of longevity.

Salminen A, Kaarniranta K, Kauppinen A.

Cell Signal. 2017 Dec;40:10-21. doi: 10.1016/j.cellsig.2017.08.009. Epub 2017 Aug 24. Review.

PMID:
28844867
29.

Drug-Induced Liver Injury in Children: Clinical Observations, Animal Models, and Regulatory Status.

Shi Q, Yang X, Greenhaw JJ, Salminen AT, Russotti GM, Salminen WF.

Int J Toxicol. 2017 Sep/Oct;36(5):365-379. doi: 10.1177/1091581817721675. Epub 2017 Aug 18. Review.

PMID:
28820004
30.

Sleep disturbance by pramipexole is modified by Meis1 in mice.

Salminen AV, Schormair B, Flachskamm C, Torres M, Müller-Myhsok B, Kimura M, Winkelmann J.

J Sleep Res. 2018 Aug;27(4):e12557. doi: 10.1111/jsr.12557. Epub 2017 Jul 11.

PMID:
28695622
31.

Meis1: effects on motor phenotypes and the sensorimotor system in mice.

Salminen AV, Garrett L, Schormair B, Rozman J, Giesert F, Niedermeier KM, Becker L, Rathkolb B, Rácz I; German Mouse Clinic Consortium, Klingenspor M, Klopstock T, Wolf E, Zimmer A, Gailus-Durner V, Torres M, Fuchs H, Hrabě de Angelis M, Wurst W, Hölter SM, Winkelmann J.

Dis Model Mech. 2017 Aug 1;10(8):981-991. doi: 10.1242/dmm.030080. Epub 2017 Jun 23.

32.

Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.

Salminen A, Kaarniranta K, Kauppinen A.

Ageing Res Rev. 2017 Aug;37:79-93. doi: 10.1016/j.arr.2017.05.004. Epub 2017 May 25. Review.

PMID:
28552719
33.

DNA damage response and autophagy in the degeneration of retinal pigment epithelial cells-Implications for age-related macular degeneration (AMD).

Hyttinen JMT, Błasiak J, Niittykoski M, Kinnunen K, Kauppinen A, Salminen A, Kaarniranta K.

Ageing Res Rev. 2017 Jul;36:64-77. doi: 10.1016/j.arr.2017.03.006. Epub 2017 Mar 27. Review.

PMID:
28351686
34.

Reliability and validity of the COPE Index among caregivers of disabled people.

Juntunen K, Nikander R, Törmäkangas T, Tillman P, Salminen AL.

Appl Nurs Res. 2017 Feb;33:102-107. doi: 10.1016/j.apnr.2016.11.002. Epub 2016 Nov 9.

PMID:
28096001
35.

Psychometric evaluation of the Finnish version of the impact on participation and autonomy questionnaire in persons with multiple sclerosis.

Karhula ME, Salminen AL, Hämäläinen PI, Ruutiainen J, Era P, Tolvanen A.

Scand J Occup Ther. 2017 Nov;24(6):410-420. doi: 10.1080/11038128.2016.1272630. Epub 2017 Jan 3.

PMID:
28049364
36.

Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria.

Zhang J, Salminen A, Yang X, Luo Y, Wu Q, White M, Greenhaw J, Ren L, Bryant M, Salminen W, Papoian T, Mattes W, Shi Q.

Arch Toxicol. 2017 Aug;91(8):2921-2938. doi: 10.1007/s00204-016-1918-1. Epub 2016 Dec 28.

37.

Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease.

Salminen A, Kauppinen A, Kaarniranta K.

J Neurochem. 2017 Feb;140(4):536-549. doi: 10.1111/jnc.13932. Epub 2017 Jan 9. Review.

38.

FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process.

Salminen A, Kauppinen A, Kaarniranta K.

J Mol Med (Berl). 2017 Feb;95(2):123-131. doi: 10.1007/s00109-016-1477-1. Epub 2016 Sep 27. Review.

PMID:
27678528
39.

Update on novel imaging techniques for the detection of lymph node metastases in bladder cancer.

Salminen AP, Jambor I, Syvanen KT, Bostrom PJ.

Minerva Urol Nefrol. 2016 Apr;68(2):138-49. Review.

40.

AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms.

Salminen A, Kaarniranta K, Kauppinen A.

Biogerontology. 2016 Aug;17(4):655-80. doi: 10.1007/s10522-016-9655-7. Epub 2016 Jun 3. Review.

PMID:
27259535
41.

An asparagine residue mediates intramolecular communication in nucleotide-regulated pyrophosphatase.

Anashkin VA, Salminen A, Vorobjeva NN, Lahti R, Baykov AA.

Biochem J. 2016 Jul 15;473(14):2097-107. doi: 10.1042/BCJ20160293. Epub 2016 May 17.

PMID:
27208172
42.

Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases.

Salminen A, Kaarniranta K, Kauppinen A.

Aging Dis. 2016 Mar 15;7(2):180-200. doi: 10.14336/AD.2015.0929. eCollection 2016 Mar. Review.

43.

Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways.

Salminen A, Kaarniranta K, Kauppinen A.

Ageing Res Rev. 2016 Jul;28:15-26. doi: 10.1016/j.arr.2016.04.003. Epub 2016 Apr 6. Review.

PMID:
27060201
44.

AMPK/Snf1 signaling regulates histone acetylation: Impact on gene expression and epigenetic functions.

Salminen A, Kauppinen A, Kaarniranta K.

Cell Signal. 2016 Aug;28(8):887-95. doi: 10.1016/j.cellsig.2016.03.009. Epub 2016 Mar 20. Review.

PMID:
27010499
45.

Inflammation and its role in age-related macular degeneration.

Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K.

Cell Mol Life Sci. 2016 May;73(9):1765-86. doi: 10.1007/s00018-016-2147-8. Epub 2016 Feb 6. Review.

46.

Lymph node imaging in bladder cancer.

Salminen AP, Jambor I, Syvänen KT, Boström PJ.

Minerva Urol Nefrol. 2015 Dec 18. [Epub ahead of print]

PMID:
26684180
47.

Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease.

Salminen A, Jouhten P, Sarajärvi T, Haapasalo A, Hiltunen M.

Neurochem Int. 2016 Jan;92:13-24. doi: 10.1016/j.neuint.2015.11.005. Epub 2015 Nov 23. Review.

PMID:
26617286
48.

Quantitative PCR analysis of salivary pathogen burden in periodontitis.

Salminen A, Kopra KA, Hyvärinen K, Paju S, Mäntylä P, Buhlin K, Nieminen MS, Sinisalo J, Pussinen PJ.

Front Cell Infect Microbiol. 2015 Oct 1;5:69. doi: 10.3389/fcimb.2015.00069. eCollection 2015.

49.

Transcutaneous carbon dioxide during sleep-disordered breathing.

Rimpilä V, Hosokawa K, Huhtala H, Saaresranta T, Salminen AV, Polo O.

Respir Physiol Neurobiol. 2015 Dec;219:95-102. doi: 10.1016/j.resp.2015.10.002. Epub 2015 Oct 22.

PMID:
26474829
50.

Cystathionine β-Synthase (CBS) Domain-containing Pyrophosphatase as a Target for Diadenosine Polyphosphates in Bacteria.

Anashkin VA, Salminen A, Tuominen HK, Orlov VN, Lahti R, Baykov AA.

J Biol Chem. 2015 Nov 13;290(46):27594-603. doi: 10.1074/jbc.M115.680272. Epub 2015 Sep 23.

Supplemental Content

Loading ...
Support Center